Single dose provoke a brisk release of insulin from pancreas. It acts on Beta Cell membrane leading to enhanced calcium flux across it hence degranulation. After chronic admin, the insulinemic action of Glibenclamide declines, but improvement in glucose tolerance is maintained. Thus an oral anti-diabetic preparation with an efficient hypoglycaemic action.

Each Uncoated Tablet containsGlibenclamide I.P. 5mg

Initially 2.5mg daily as a single dose at breakfast increasing gradually by another 2-5mg (only after repreating laboratory examinations) Max 15mg daily.

Chronic Prophylaxis : 5-10mg 3-4 times daily or as required.

T: 10 Blisters of 10 Tablets each